According to King Law: The lawsuits primarily allege that manufacturers like Novo Nordisk (maker of Wegovy) failed to adequately warn patients and healthcare providers about the risks associated with these drugs, such as severe gastrointestinal complications like gastroparesis (stomach paralysis), ileus (intestinal obstruction), and recently, vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION). Prediction 2: More Emergency Room Visits Due to Adverse Effects In April 2025, Annals of Medicine reported that nearly 25,000 emergency room visits had occurred due to semaglutide adverse events in the years 2022 and 2023
In addition, CPT1 and CPT2 are highly expressed in chronic lymphoblastic leukemia cells (Liu et al., 2016)
Recovery and Results As there is no downtime associated with peptide therapy, each patient will be able to return to their daily schedule immediately following the treatment
Additionally, if the dose remains subtherapeutic for an individual's physiology, the expected appetite reduction may not materialise
Curr Opin Pharmacol ottobre
Peaks were called using MACS2 (v2.2.6) with the parameters -q 0.05 --nomodel --nolambda